Patients and treatment
AML
AML
This investigator-initiated trial was approved by the MD Anderson Institutional Review Board, registered on ClinicalTrails.gov (NCT03634228) and conducted in accordance with the Declaration of Helsinki. Eligible patients were adults ≥ 18 years of age with a diagnosis of AML (R/R AML, or ND AML not eligible for intensive chemotherapy due to age or comorbidities) according to World Health Organization 2016 criteria. Key exclusion factors included the presence of a 